PARK2 Regulates eIF4B-Driven Lymphomagenesis
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Cancer Research"
DOI: 10.1158/1541-7786.mcr-21-0729
Abstract: Abstract Patients with high-risk diffuse large B-cell lymphoma have poor outcomes following first-line cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab (R-CHOP); thus, treatment of this fatal disease remains an area of unmet medical need and requires… read more here.
Keywords: park2 regulates; lymphomagenesis; protein translation; park2 ... See more keywords